Routine baseline liver function test (LFT) is recommended prior to starting the standard four-drug therapy for suspect or active TB disease. If the tests are normal, no further tests are required unless symptoms develop. I MONITORING AIT. If results less than 2X upper limits and no side effects repeat in one month. Consult with physician when greater than 2X upper limit. If any of LFT > 3X upper limit of normal {ULN) at any time, consider stopping therapy and following protocol. Do LFTs before you start AIT. AIT is started if the LFTs are less than two times normal.
WHEN DO WE CALL A IT- INDUCED
HEPATITIS??? Drug induced hepatotoxicity is defined as: ****AST/ALT>= 3x ULNwith the presence of symptoms; OR ****AST/ALT >Sx ULN in the absence of symptoms; OR ****disproportional increase in alkaline phosphatase (ALP) and total bilirubin.
MANAGEMENT. The management of AIT induced hepatitis depends upon three factors ...
1. Subjective condition of patient
2. LFTs 3. Symptomatic/Asymptomatic WHAT TO DO??? Once AIT induced hepatitis occurs, STOP ALL DRUGS IMMEDIATELY!!!
Send this labwork
**CBC **LFTs **RPM **Hepatitis A, Band C serology **Consider any other heptaotoxic drug or alcohol consumption
Consult with an expert who is
familiar with the management of hepatotoxicity. Whether and when to restart the drugs depends upon the subjective condition of the patient.
(A) If the patient is stable and
smear negative: Stop all AIT and no need to start any other drug therapy. Do LFTs twice weekly and restart AIT once the LFTs are less than two times the upper limit of normal. Restart pro- tocol is the same as for unstable and smear positive patients.
(BJ If the patient is unstable and
smear positive: (If the patient is severely ill with TB and it is considered unsafe to stop all AIT) Stop all ongoing AIT and shift the patient to SLE ( streptomycin + levofloxacin + ethambutol) Continue serial monitoring of LFTs twice weekly. The first line AIT drugs will be restarted once ALT is less than two times the upper limit of normal. RESTART PROTOCOL/ RECHALLENGING AIT. Once LFTs are less than twice the upper limit of normal... introduce primary AIT in the sequence of RIP (rest in peace...Rifampicin then /soniazid then Pyranazimide).
1. Continue checking LFT. If LFT
<2x ULN, re-challenge first with Rifampin because of its efficacy and is least likely to cause hepatotoxicity. 2. If LFT does not increase after 1 week, then /NH should be added to the regimen. 3. Pyrazinamide (PZA) can be added next (1 week after /NH) if LFT does not increase.
Drugs are added in a manner that
initially half of dose is introduced for 3 days and if the patient tolerates only then full blown dose of the drug is given with monitoring of LFTs. There should be a gap of at least one week between two rechallenged AIT drugs. Important point If at any time of re-challenged period, symptoms recur or AST increases, the last drug added S~·h·. -a-. lu- . ,J d·- b- . . .· ·. . .· e· · · s·-- _:_ . t-o· :·-pp-•_-_.e-· . ·i d-·-- . . . .· _ ..· . . . . -- !II'